Genzyme (Nasdaq: GENZ) reports Q1 EPS of $0.95, 2 cents better than the analyst estimate of $0.93.
Revenues ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE